| ER | endoplasmic reticulum |
| ROS | reactive oxygen species |
| EMT | epithelial-to-mesenchymal transition |
| NAFLD | non-alcoholic fatty liver disease |
| TNF-α | tumor necrosis factor-α |
| IL | interleukin |
| I/R | ischemic/reperfusion |
| PD | Parkinson’s disease |
| TBI | traumatic brain injury |
| Nrf2 | nuclear factor erythroid 2-related factor 2 |
| EGFR | epidermal growth factor receptor |
| VEGF | vascular endothelial growth factor |
| HIF-1 | hypoxia-inducible factor-1 |
| STAT3 | signal transducer and activator of transcription 3 |
| TLRs | toll-like receptors |
| NF-κB | nuclear factor-kappaB |
| PC | prostate cancer |
| UPR | unfolded protein response |
| PERK | PRKR-like ER kinase |
| elF2α | eukaryotic translation initiation factor 2α |
| GRP78 | 78 kDa glucose-regulated protein |
| OC | ovarian cancer |
| GC | gastric cancer |
| 5mC | 5-methylcytosine |
| 5hmC | 5-hydroxymethylcytosine |
| miR | microRNA |
| TGF-β | transforming growth factor-beta |
| HK | hexokinase |
| HCC | hepatocellular carcinoma |
| ECM | extracellular matrix |
| 5-FU | 5-Fluorouracil |
| CRC | colorectal cancer |
| LC-3II | light chain-3II |
| mTOR | mammalian target of rapamycin |
| PPARα | Peroxisome proliferator-activated receptor alpha |
| CYP | cytochrome C |
| DTX | docetaxel |
| FDA | Food and Drug Administration |
| TIMPs | tissue inhibitors of metalloproteinases |
| lncRNAs | long non-coding RNAs |
| circRNAs | circular RNAs |